Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca Plc (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca Plc)

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca Plc (LSE: AZN) Latest News

Investing Articles

3 Reasons To Dump AstraZeneca plc For GlaxoSmithKline plc

| Rupert Hargreaves

AstraZeneca plc's (LON: AZN) recent rally has been impressive but it could be time to sell out in favour of…

Read more »

Investing Articles

Is AstraZeneca plc A Super Income Stock?

| Peter Stephens

Does AstraZeneca plc (LON: AZN) have the right credentials to be classed as a very attractive income play?

Read more »

Investing Articles

How Safe Is Your Money In AstraZeneca plc?

| Roland Head

As profits continue to fall at AstraZeneca plc (LON:AZN), is the firm's dividend safe or could it come under threat?

Read more »

Investing Articles

The Reasons AstraZeneca plc Won’t Make You Wealthy

| Mark Stones

Why I wouldn't make AstraZeneca plc (LON: AZN) a core share in my portfolio.

Read more »

Investing Articles

The Contrary Investment Case: 3 Reasons To Stock Up On AstraZeneca plc

| Royston Wild

Royston Wild looks at why AstraZeneca plc (LON: AZN) could be a canny share purchase.

Read more »

Investing Articles

Why AstraZeneca plc Should Be A Candidate For Your 2014 ISA

| Alan Oscroft

AstraZeneca plc (LON: AZN) is heading back to growth.

Read more »

Investing Articles

Should You Dump AstraZeneca plc In Favour Of GlaxoSmithKline plc?

| Rupert Hargreaves

AstraZeneca plc (LON: AZN) currently trades at a premium to GlaxoSmithKline plc (LON: GSK); does it deserve it?

Read more »

Investing Articles

3 Hazardous Reasons To Steer Clear Of AstraZeneca plc

| Royston Wild

Royston Wild looks at why AstraZeneca plc (LON: AZN) is an exceptionally risky stock selection.

Read more »

Investing Articles

Can AstraZeneca plc Make £5 Billion Profit?

| Rupert Hargreaves

Will AstraZeneca plc (LON: AZN) be able to drive profits higher?

Read more »

Investing Articles

Is AstraZeneca plc Dependent On Debt?

| Peter Stephens

Are debt levels at AstraZeneca plc (LON: AZN) becoming detrimental to its future prospects?

Read more »

Investing Articles

GlaxoSmithKline plc Vs AstraZeneca plc — Which Is The Better Bet For Income And Growth?

| Rupert Hargreaves

GlaxoSmithKline plc (LON:GSK) and AstraZeneca plc (LON:AZN) are both great companies, but which one should you choose?

Read more »

Investing Articles

David & Goliath: AstraZeneca versus Hikma Pharmaceuticals

| Kevin Godbold

Which company is most attractive, AstraZeneca or its smaller rival Hikma Pharmaceuticals?

Read more »